A Phase I Study to Investigate the Absorption, Metabolism and Excretion of [14C]-Bilastine Following Oral Administration to Healthy Volunteers
The primary objective of the study is to define the absorption and excretion kinetics of bilastine in man following oral administration, and to investigate the nature of the metabolites present in plasma and excreta. The secondary objective of the study is to assess the safety and tolerability of bilastine
100 项与 CR Laboratories Preclinical Services Ltd 相关的临床结果
0 项与 CR Laboratories Preclinical Services Ltd 相关的专利（医药）
100 项与 CR Laboratories Preclinical Services Ltd 相关的药物交易
100 项与 CR Laboratories Preclinical Services Ltd 相关的转化医学
